These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 11378098

  • 21. Montelukast for bronchiolitis obliterans syndrome after lung transplantation: a pilot study.
    Verleden GM, Verleden SE, Vos R, De Vleeschauwer SI, Dupont LJ, Van Raemdonck DE, Vanaudenaerde BM.
    Transpl Int; 2011 Jul; 24(7):651-6. PubMed ID: 21401732
    [Abstract] [Full Text] [Related]

  • 22. Montelukast in respiratory syncytial virus postbronchiolitis.
    López-Andreu JA, Cortell-Aznar I, Ruiz-García V.
    Am J Respir Crit Care Med; 2004 Jun 01; 169(11):1255; author reply 1255-6. PubMed ID: 15161615
    [No Abstract] [Full Text] [Related]

  • 23. Severe erythrodermic atopic dermatitis treated with montelukast.
    Broshtilova V, Antonov D, Bardarov E, Tsankov N.
    Skinmed; 2003 Jun 01; 2(2):134-6. PubMed ID: 14673317
    [No Abstract] [Full Text] [Related]

  • 24. Can montelukast sodium be an alternative treatment in the treatment of interstitial cystitis?
    Gunizi OC, Kol A, Gunizi H.
    Niger J Clin Pract; 2023 Apr 01; 26(4):397-403. PubMed ID: 37203102
    [Abstract] [Full Text] [Related]

  • 25. Effects of long-term treatment with montelukast in mild cystic fibrosis (long term treatment with montelukast in cystic fibrosis).
    Schmitt-Grohé S, Eickmeier O, Naujoks C, Schubert R, Lentze MJ, Zielen S, Rietschel E.
    Respir Med; 2007 Mar 01; 101(3):684. PubMed ID: 17187974
    [No Abstract] [Full Text] [Related]

  • 26. Montelukast: use in pediatric patients with eosinophilic gastrointestinal disease.
    Vanderhoof JA, Young RJ, Hanner TL, Kettlehut B.
    J Pediatr Gastroenterol Nutr; 2003 Feb 01; 36(2):293-4. PubMed ID: 12548071
    [No Abstract] [Full Text] [Related]

  • 27. [Successful and effective: Montelukast in clinical practice].
    Internist (Berl); 1999 Dec 01; 40(12 Suppl Montelukas):1-4. PubMed ID: 10635479
    [No Abstract] [Full Text] [Related]

  • 28. Montelukast sodium in cystic fibrosis.
    Morice AH, Kastelik JA, Aziz I.
    Thorax; 2001 Mar 01; 56(3):244-5. PubMed ID: 11245147
    [No Abstract] [Full Text] [Related]

  • 29. The effect of montelukast sodium on the duration of effusion of otitis media.
    Combs JT.
    Clin Pediatr (Phila); 2004 Mar 01; 43(6):529-33. PubMed ID: 15248005
    [Abstract] [Full Text] [Related]

  • 30. Montelukast in childhood asthma.
    Mehta PN.
    Indian Pediatr; 2000 Nov 01; 37(11):1201-9. PubMed ID: 11086302
    [No Abstract] [Full Text] [Related]

  • 31. Is montelukast indicated for treatment of chronic rhinosinusitis with polyposis?
    Smith TL, Sautter NB.
    Laryngoscope; 2014 Aug 01; 124(8):1735-6. PubMed ID: 24338615
    [No Abstract] [Full Text] [Related]

  • 32. Montelukast as a treatment modality for eosinophilic gastroenteritis.
    De Maeyer N, Kochuyt AM, Van Moerkercke W, Hiele M.
    Acta Gastroenterol Belg; 2011 Dec 01; 74(4):570-5. PubMed ID: 22319970
    [Abstract] [Full Text] [Related]

  • 33. Efficacy and tolerability of montelukast as a therapeutic agent for severe atopic dermatitis in adults.
    Nettis E, Pannofino A, Fanelli M, Ferrannini A, Tursi A.
    Acta Derm Venereol; 2002 Dec 01; 82(4):297-8. PubMed ID: 12361137
    [No Abstract] [Full Text] [Related]

  • 34. Montelukast and maintenance of steroid-induced remission in eosinophilic esophagitis.
    Filik L.
    Dig Dis Sci; 2012 Jan 01; 57(1):258-9. PubMed ID: 21987280
    [No Abstract] [Full Text] [Related]

  • 35. Anti-inflammatory effects of montelukast in mild cystic fibrosis.
    Schmitt-Grohé S, Eickmeier O, Schubert R, Bez C, Zielen S.
    Ann Allergy Asthma Immunol; 2002 Dec 01; 89(6):599-605. PubMed ID: 12487226
    [Abstract] [Full Text] [Related]

  • 36. Montelukast for respiratory syncytial virus bronchiolitis: significant effect or provocative findings?
    Szefler SJ, Simoes EA.
    Am J Respir Crit Care Med; 2003 Feb 01; 167(3):290-1. PubMed ID: 12554617
    [No Abstract] [Full Text] [Related]

  • 37. Montelukast can reduce the severity and extent of atopic dermatitis.
    Holme H, Winckworth LC.
    J Paediatr Child Health; 2013 May 01; 49(5):412-5. PubMed ID: 23647765
    [No Abstract] [Full Text] [Related]

  • 38. Use of montelukast as steroid-sparing agent for recurrent eosinophilic gastroenteritis.
    Schwartz DA, Pardi DS, Murray JA.
    Dig Dis Sci; 2001 Aug 01; 46(8):1787-90. PubMed ID: 11508684
    [Abstract] [Full Text] [Related]

  • 39. Asthma plus migraine in childhood and adolescence: prophylactic benefits with leukotriene receptor antagonist.
    de Souza Carvalho D, Fragoso YD, Coelho FM, Pereira MM.
    Headache; 2002 Aug 01; 42(10):1044-7. PubMed ID: 12453038
    [No Abstract] [Full Text] [Related]

  • 40. Montelukast and fluticasone propionate.
    Nathan R.
    Ann Allergy Asthma Immunol; 2003 Dec 01; 91(6):585; author reply 586-7. PubMed ID: 14700445
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.